Task: Answer the multiple choice question.
Question: Which drug exhibits a -70.364% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] CC(C)(Oc1ccc(Cl)cc1)C(=O)NC1CCN(Cc2ccccc2)CC1
[b] COC(=O)c1c(C)[nH]c(C)c1-c1cccc([N+](=O)[O-])c1
Answer: a. CC(C)(Oc1ccc(Cl)cc1)C(=O)NC1CCN(Cc2ccccc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)(Oc1ccc(Cl)cc1)C(=O)NC1CCN(Cc2ccccc2)CC1
CC(C)(Oc1ccc(Cl)cc1)C(=O)NC1CCN(Cc2ccccc2)CC1
N-(1-benzylpiperidin-4-yl)-2-(4-chlorophenoxy)-2-methylpropanamide